Cargando…
Internal Medicine Evidence.
"In this volume, we aspired to select, summarize, and contextualize 100 of the most practice-changing articles in the field of Iinternal Mmedicine. As practicing clinicians, medical educators, and lifelong learners, we felt particularly drawn to the challenge of exploring how evidence guides cl...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Philadelphia :
Wolters Kluwer Health,
2017.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Intro; Title Page; Copyright; Dedication; Contributors; Preface; Acknowledgments; Contents; SECTION 1: CARDIOLOGY; 1. Rate Versus Rhythm Control in Atrial Fibrillation: The AFFIRM Trial; 2. Angioplasty Versus Streptokinase in Myocardial Infarction; 3. First-Step Antihypertensive Therapy: The ALLHAT Trial; 4. Heart Failure Treatment for African Americans: The A-HeFT Trial; 5. Dual Antiplatelet Therapy in Non-ST-Elevation ACS: The CURE Trial; 6. ACE Inhibitors in Congestive Heart Failure: The CONSENSUS Trial; 7. CRT in Advanced Heart Failure: The COMPANION Trial.
- 8. Beta Blockers in Chronic Heart Failure: The COMET Trial9. Antiplatelet Therapy for Preventing Vascular Events; 10. Statin Therapy After ACS: PROVE IT-TIMI 22; 11. Transcatheter Aortic Valve Implantation: The PARTNER B Trial; 12. Angioplasty Versus t-PA in Myocardial Infarction: The PAMI-1 Study; 13. Aspirin and Thrombolysis in Myocardial Infarction: The ISIS-2 Trial; 14. Heparin in ACS without ST Elevation; 15. PCI Versus CABG for Severe CAD: The SYNTAX Trial; 16. Antiarrhythmics and ICDs in CHF: The SCD-HeFT Trial; 17. ACE Inhibitors in LV Dysfunction: The SAVE Trial.
- 18. Dabigatran for Atrial Fibrillation: The RE-LY Trial19. Spironolactone in Severe HF: The RALES Trial; 20. Cholesterol Lowering in Coronary Artery Disease: The 4S Trial; SECTION 2: CRITICAL CARE; 21. Glucose Control in ICU Patients: The NICE-SUGAR Trial; 22. Therapeutic Hypothermia after Cardiac Arrest: The HACA Trial; 23. Corticosteroids in Septic Shock: The CORTICUS Trial; 24. Low Tidal Volume Ventilation for Acute Respiratory Distress Syndrome: The ARMA Trial; 25. Timing of Antibiotics in Septic Shock; 26. Paired Weaning Protocol for Mechanical Ventilation and Sedation: The ABC Trial.
- 27. Blood Transfusion for ICU Patients: The TRICC Trial28. Choice of First Vasopressor in Shock: The SOAP II Trial; 29. Revascularization for Cardiogenic Shock after Myocardial Infarction: The SHOCK Trial; 30. Early Goal-Directed Therapy in Sepsis; 31. Prone Positioning in Severe ARDS: The PROSEVA Trial; SECTION 3: ENDOCRINOLOGY; 32. ACE Inhibitors for Diabetic Nephropathy; 33. Bisphosphonates and Fracture Risk: The FIT Trial; 34. Insulin Therapy and Diabetes Complications: The DCCT Trial; 35. Hormone Replacement Therapy in Postmenopausal Women: The Women's Health Initiative (WHI) Trial.
- 36. Lifestyle Intervention and Metformin in Diabetes: The DPP StudySECTION 4: GASTROENTEROLOGY; 37. Antibiotics in Variceal GI Bleeding; 38. Transfusion in UGIB; 39. PPI Before Endoscopy in UGIB; 40. Albumin in SBP; 41. 10-Year Interval for Screening Colonoscopy; 42. SAAG in the Diagnosis of Ascites; 43. Rifaximin in Hepatic Encephalopathy; 44. "Top-Down" Therapy for Crohn Disease; SECTION 5: HEMATOLOGY; 45. Plasma Exchange in Thrombotic Thrombocytopenic Purpura; 46. Natural History and Prognosis of MGUS; 47. The JAK2 Mutation in Myeloproliferative Neoplasms; 48. Imatinib for CML.